The lack of financing dramatically lowers the number of spin-outs from Universities and research institutions which passes the initial phase, where they are financed by public pre-seed financing.
Therefore Bioforum Oulu, Finland, is taking the lead in creating a "Top of Europe" financing network to assist closing the financial gap, which is a barrier for the exploitation of academic research in SME´s throughout the region. The Top of Europe financing network will be the theme for a workshop to be held 9th of June in Göteborg, where experts within financing of life sciences and biotech will discuss how to proceed in order to create a successful collaboration.
Program Director Tuula Palmén, Bioforum Oulu, says "We hope to promote the establishment of the Top of Europe financing network through dialogue with key stakeholders like private investors, SME´s, national and regional innovation and research agencies plus decision- and opinion makers. In order to strengthen competitiveness of the Baltic Sea Region we need to focus on the development of research based SME´s - otherwise we will loose ground to low costs countries".
The workshop in Göteborg is part of an EU co-funded project (FP 7) "Bridge-BSR" with 7 partners in addition to Bioforum Oulu: BioCan Valley, Estonian Biotech Association, IPPT-PAN, Latvian Association of Biotechnology, Medicon Valley Alliance, ScanBalt and Steinbeis Team North East. Bridge-BSR aims to bridge academic research and SME´s within life sciences and biotechnology in te Baltic Sea Region - ScanBalt BioRegion.
For further information please contact Tuula Palmén at firstname.lastname@example.org, Tel: +358 50 4617290, www.businessoulu.com
About Bioforum Oulu: Bioforum Oulu gathers together biotech companies, universities and R&D organisations in the Oulu region, Finland, and stimulates their co-operation. Bioforum Oulu works closely with other players in the region and also carries out spearhead projects named in the Oulu Growth Agreement. The intent is to develop new products and services that enhance people's health and well-being and to create new business in the field.
About ScanBalt BioRegion: ScanBalt BioRegion is composed of public and private Life Science and biotechnology actors in the Nordic countries, Balticum, Poland, Northern part of Germany and North western Russia. The ScanBalt BioRegion has 11 countries and 85 million people, more than 60 universities and 2149 life science/biotech companies including 671 research based biotech SME's.
Peter Frank | idw
Frugal Innovations: when less is more
19.04.2017 | Fraunhofer-Institut für Arbeitswirtschaft und Organisation IAO
Europe's microtechnology industry is attuned to growth
10.03.2017 | IVAM Fachverband für Mikrotechnik
Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.
Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....
Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.
The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....
An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.
We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...
Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.
Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...
An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...
24.05.2017 | Event News
23.05.2017 | Event News
22.05.2017 | Event News
26.05.2017 | Life Sciences
26.05.2017 | Life Sciences
26.05.2017 | Physics and Astronomy